Automating QC of Therapeutic Oligonucleotides in a Regulated Manufacturing Environment

In this Case Study Dr Juliet Padden and Dr Heiner Apeler describe how Bayer Pharmaceuticals worked together with Genedata to develop a fully automated data processing, analysis, and reporting workflow for QC of therapeutic oligonucleotides that addressed and overcame the following key challenges:

• Implementing an end-to-end software solution for oligonucleotide analysis 
• Deploying the solution into a GMP environment 
• Streamlining and automating the entire process 
• Meeting a range of new up- and downstream analytical demands